I am a
Home I AM A Search Login

Papers of the Week

2022 Jul 19

Eur J Hosp Pharm

Patient perspectives of successful adalimumab biosimilar transitioning in Crohn’s disease: an interview study.


Transition from originator biological medicines to their biosimilar equivalents is now part of routine clinical practice, but there is little understanding of patient experiences, which influence adherence and overall satisfaction with care. Understanding this will help ensure future switches adequately address patients' concerns and expectations leading to better outcomes for all stakeholders.